View Post

UT Southwestern Researchers find evidence a cancer drug may be extended to many more patients

In In The News by Barbara Jacoby

Source: UT Southwestern Medical Center From: PR Newswire A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating all cancers where the drugs are used, including ovarian and prostate cancers. The new study also revealed a potential biomarker indicating when …

View Post

Breast cancer gene mutation clinical trial to take place in Australia

In Clinical Trials by Barbara Jacoby

By: Meagan Dillon and Leah MacLennan From: abc.net.au Breast cancer is a disease that predominantly impacts women, but it is not unheard of for men to also carry a rare genetic mutation that significantly increases the risk. Helen Hicks’s husband Tony Ransom is in that category — but the Adelaide couple will not know if the mutation has been passed …

View Post

His single-cell solution is revolutionizing cancer research

In In The News by Barbara Jacoby

By: Clayton Boldt, Ph.D. From: mdanderson.org Nicholas Navin wanted to better understand how tumors grow and evolve, so he found a way to analyze the DNA of individual cells Frustration often leads to innovation. Thomas Edison himself called discontent the “first necessity of progress.” For Nicholas Navin, Ph.D., it drove him to pioneer a technique that has revolutionized the way researchers are able …

View Post

Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting

In Clinical Trials by Barbara Jacoby

Source: Constellation Pharmaceuticals , Inc. From: globenewswire.com Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patients Recently initiated Phase 2 portion of ProSTAR includes randomized testing of CPI-1205 in combination with enzalutamide versus enzalutamide alone, as well as CPI-1205 in combination with abiraterone Initial update from Phase 2 portion of ProSTAR expected in …

View Post

FDA Warns About Robotic Mastectomy, Other Surgeries

In In The News by Barbara Jacoby

By: Nick Mulcahy From: medscape.com The US Food and Drug Administration (FDA) today issued a safety communication to healthcare providers about the use of robotically assisted surgical devices for mastectomy and other cancer-related surgeries that are not already FDA approved. The agency urged caution about any such use. Robotic devices are approved for use in prostate cancer but not in most …

View Post

Racial disparities in US cancer deaths are shrinking, study finds

In In The News by Barbara Jacoby

Posted By: CNN Wire From: wtvr.com Racial disparities in cancer deaths between black and white patients in the United States are receding — but more progress is needed to completely close the gap for some cancer types and age groups, according to a new study. Among men, the overall cancer death rate was 47% higher for blacks than for whites …

View Post

Veru Initiates Clinical Trial for Proprietary, Novel, First-in-Class Drug for Advanced Prostate Cancer

In Clinical Trials by Barbara Jacoby

Source: Veru, Inc. From: globenewswire.com Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that it has initiated and enrolled the first patient in a clinical trial of its proprietary, next generation prostate cancer drug, VERU-111. The open-label Phase 1b/2 clinical trial for VERU-111, a novel oral drug, will be evaluated in men with metastatic refractory prostate …

View Post

Living With Cancer: Some Men With Prostate Cancer Opt Out of Surgery

In In The News by Barbara Jacoby

From: newsroom.cedars-sinai.org Dale White was diagnosed with prostate cancer six years ago. His doctor told him that surviving prostate cancer depended on one treatment option: surgery. ”I was shocked. I thought that was too radical,” said White, 69. ”So I searched for other options and ended up at Cedars-Sinai, where Dr. Posadas told me I was a good candidate for active …

View Post

Hormone Therapy Can Make Prostate Cancer Worse, Study Finds

In In The News by Barbara Jacoby

Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostate cancer is the second-leading cause of cancer death in men, behind lung cancer, killing …

View Post

What Is Active Surveillance for Breast Cancer?

In In The News by Barbara Jacoby

By Elaine K. Howley From: health.usnews.com Cancer cells don’t all grow and spread at the same speed. Some, as with prostate cancer, can be slow-growing, so oncologists have taken the approach at times that it’s safe to do so-called watchful waiting, or active surveillance, to see if the cancer starts to cause problems before they undertake invasive treatments. Active surveillance …